AJ Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-314
Closed -$245K 38
2025
Q2
$245K Sell
314
-2
-0.6% -$1.55K 0.11% 34
2025
Q1
$261K Buy
+316
New +$263K 0.13% 31
2024
Q2
Sell
-561
Closed -$436K 39
2024
Q1
$436K Buy
561
+38
+7% +$27K 0.24% 30
2023
Q4
$305K Buy
+523
New +$305K 0.19% 32

Other funds holding LLY

AJ Advisors's LLY Position: Q3 2025 in Review

AJ Advisors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 314 shares — an estimated $245K sold.

AJ Advisors first reported a position in LLY in Q4 2023 and held it in 4 quarters. The position peaked at $436K in Q1 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • AJ Advisors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • AJ Advisors sold 314 Eli Lilly shares in Q3 2025, an estimated $245K.
  • AJ Advisors first reported a position in Eli Lilly in Q4 2023 and held it in 4 quarters.
  • AJ Advisors's Eli Lilly position peaked at $436K in Q1 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on AJ Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.